-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
Pharma CEO Martin Shkreli Speaks Out After Arrest and Resignation
The drugmaker sued him for $65 million, saying he had breached his duty to the company.
Advertisement
“It was hacked”, Craig Stevens, a spokesman for the former chief executive of Turing Pharmaceuticals, said in an email.
The 32-year-old’s tweet, which he pinned to the top of his account, comes after his resignation from Turing on Friday and his arrest on Thursday for alleged securities fraud.
Retrophin ousted Shkreli previous year.
Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI after a federal investigation. Photos of him, wearing a grey hoodie as he was escorted by authorities, spread on the Internet like wildfire, generating social media posts celebrating his apparent fall. One tweet asked, receiving some of the highest number of retweets out of the seven released within the span of one hour of each other.
Turing, with offices in NY and Switzerland, bought US rights to sell Daraprim in August, when it had no competition.
The only response he appears to have to anything related, is whether the drug Daraprim would be unavailable if either Turing Pharmaceutical were to go under or if Shkreli is no longer involved.
Alec Tabak/for New York Daily News Martin Shkreli in custody on Thursday.
“Turing’s interim CEO Ron Tilles should immediately roll back the company’s unconscionable 5,000 percent price hike on Daraprim, a crucial treatment for many pregnant women and people living with HIV, and restore the drug to its original cost”.
Advertisement
Shkreli recently became the CEO of a second company, KaloBios Pharmaceuticals, Inc., based in South San Francisco, California. Their price fell to $23.59.